Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Oxidized resorbable cellulose (Gelita-cel) causing foreign body reaction in the mediastinum

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. What is the optimal level of suction on digital chest drainage devices following pulmonary lobectomy?

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Lung volume reduction surgery as salvage procedure after previous use of endobronchial valves

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Preoperative pulmonary function in all comers for cardiac surgery predicts mortality†

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Influence of external stenting on venous graft flow parameters in coronary artery bypass grafting: a randomized study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Simulation-based VATS resection of the five lung lobes: a technical skills test

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Correlation of MET-Receptor Overexpression with MET Gene Amplification and Patient Outcome in Malignant Mesothelioma

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Developing the surgical technique reporting checklist and standards: a study protocol

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Evidence on reporting guidelines for surgical technique in clinical disciplines: a scoping review protocol

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations

Different types of oxidized cellulose have been used for haemorrhage control in thoracic surgery, abdominal surgery and neurosurgery. Oxidized resorbable cellulose (Gelita-cel) is a new haemostatic agent. Once saturated with blood, it swells and makes a gelatinous mass that formats as a fibrin clot. We have performed a prospective observational cohort study of patients operated for lung cancer or suspected lung cancer using Gelita-cel as a haemostatic agent. Between October 2010 and April 2012, 477 patients were operated in our department for lung cancer. Gelita-cel was used in 200 patients due to minor intraoperative haemorrhage after lymph node resection from Stations 2 to 11. During follow-up for lung cancer, computed tomography, which was performed 4-60 months after the primary operation, showed enlarged lymph nodes in the mediastinum in 16 patients. Endoscopic bronchial ultrasonographic biopsies of the lymph nodes showed foreign body material and granulomatous inflammation, and no sign of lung cancer recurrence. Gelita-cel has a high risk of causing granuloma and should not be used as a haemostatic agent in thoracic surgery.

Original languageEnglish
JournalInteractive Cardiovascular and Thoracic Surgery
Volume27
Issue number6
Pages (from-to)881-883
Number of pages3
ISSN1569-9293
DOIs
Publication statusPublished - 1 Dec 2018

ID: 56416360